[go: up one dir, main page]

US20180373061A1 - Automatically-adapting ophthalmic lens and intraocular lens - Google Patents

Automatically-adapting ophthalmic lens and intraocular lens Download PDF

Info

Publication number
US20180373061A1
US20180373061A1 US15/638,835 US201715638835A US2018373061A1 US 20180373061 A1 US20180373061 A1 US 20180373061A1 US 201715638835 A US201715638835 A US 201715638835A US 2018373061 A1 US2018373061 A1 US 2018373061A1
Authority
US
United States
Prior art keywords
gel layer
reversible
reversible gel
adapting
automatically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US15/638,835
Other versions
US10162193B1 (en
Inventor
Hsiu-Wen Chien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Miics and Partners Shenzhen Co Ltd
Original Assignee
Miics and Partners Shenzhen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miics and Partners Shenzhen Co Ltd filed Critical Miics and Partners Shenzhen Co Ltd
Assigned to HON HAI PRECISION INDUSTRY CO., LTD. reassignment HON HAI PRECISION INDUSTRY CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHIEN, HSIU-WEN
Assigned to SCIENBIZIP CONSULTING(SHENZHEN)CO.,LTD. reassignment SCIENBIZIP CONSULTING(SHENZHEN)CO.,LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HON HAI PRECISION INDUSTRY CO., LTD.
Assigned to MIICS & PARTNERS (SHENZHEN) CO., LTD. reassignment MIICS & PARTNERS (SHENZHEN) CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SCIENBIZIP CONSULTING(SHENZHEN)CO.,LTD.
Application granted granted Critical
Publication of US10162193B1 publication Critical patent/US10162193B1/en
Publication of US20180373061A1 publication Critical patent/US20180373061A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/02Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04Contact lenses for the eyes
    • G02C7/049Contact lenses having special fitting or structural features achieved by special materials or material structures
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/02Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04Contact lenses for the eyes
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C2202/00Generic optical aspects applicable to one or more of the subgroups of G02C7/00
    • G02C2202/06Special ophthalmologic or optometric aspects

Definitions

  • the subject matter herein generally relates to eye health, and automatically-adapting ophthalmic lens and intraocular lens.
  • Ophthalmic/intraocular lens are commonly worn by users to correct vision, or for cosmetic or therapeutic reasons.
  • radius of curvature of an ophthalmic/intraocular lens is predetermined.
  • radiuses of cornea curvature of different users are very different, and an ophthalmic/intraocular lens having a predetermined radius of curvature probably will not be matched with the corneas of different users.
  • FIG. 1 is a cross-sectional view of an ophthalmic lens according to an exemplary embodiment.
  • FIG. 2 is a cross-sectional view of an intraocular lens according to an exemplary embodiment.
  • FIG. 1 illustrates an exemplary embodiment of an automatically-adapting ophthalmic lens 1 including a matrix 10 and a reversible gel layer 20 .
  • the matrix 10 and the reversible gel layer 20 all can be made of hydrogel or silicone hydrogel.
  • the matrix 10 and the reversible gel layer 20 are made of hydrogel
  • the matrix 10 and the reversible gel layer 20 are made of silicone hydrogel
  • the matrix 10 includes a back surface 101 .
  • the reversible gel layer 20 is formed on the back surface 101 .
  • the reversible gel layer 20 includes a contact surface 201 away from the back surface 101 .
  • radius of curvature of the contact surface 101 can be 8.8 millimeters, 8.6 millimeters, or 8.4 millimeters, before the ophthalmic lens 1 is worn.
  • the reversible gel layer 20 can have a reversible chemical reaction which changes its shape.
  • the physical movement of molecular structure in the reversible gel layer 20 being limited by the eye of wearer, the reversible gel layer 20 can be closely in contact with eyeball of the wearer, thus radius of curvature of the contact surface 201 changes to match radius of corneal curvature of eye of wearer.
  • the reversible gel layer 20 can be a thermally reversible gel layer, a light induced reversible gel layer, a redox agent induced reversible gel layer, or an acid-base (pH value) induced reversible gel layer.
  • the reversible gel layer 20 can includes thermally reversible block copolymer, and the thermally reversible block copolymer can have a reversible chemical reaction which changes its shape under a change of temperature.
  • thermally reversible block copolymer can have a reversible chemical reaction which changes its shape under a change of temperature.
  • the block copolymer When the ophthalmic lens 1 is worn, the block copolymer can have a reversible chemical reaction under the body temperature, then the reversible gel layer 20 can be closely in contact with eyeball of the wearer, thus radius of curvature of the contact surface 101 changes to equal to radiuses of corneal curvature of the eye of wearer.
  • the block copolymer can be ethylene-oxide-propylene-oxide block copolymer, polyoxyethylene-polyoxypropylene block copolymer, or other thermally reversible block copolymer.
  • the reversible gel layer 20 When the reversible gel layer 20 is a light induced reversible gel layer, the reversible gel layer 20 can have a reversible chemical reaction under an irradiation by light. When the ophthalmic lens 1 is worn, the reversible gel layer 20 can have a reversible chemical reaction under sunlight or ultraviolet (UV) light, then the reversible gel layer 20 can be closely in contact with eyeball of the wearer, thus radius of curvature of the contact surface 101 can be changed to equal corneal radius of the eye of wearer.
  • UV ultraviolet
  • the reversible gel layer 20 can include one or more of disulfide chemical bonds, hydrazone chemical bonds, phenyl boronic acid chemical bonds, metal coordination bonds, and cyclodextrin host-guest interaction bonds.
  • the reversible gel layer 20 can further include catalyst of light.
  • the reversible gel layer 20 When the reversible gel layer 20 is a redox agent induced reversible gel layer, the reversible gel layer 20 can have a reversible chemical reaction under an oxidizing agent or a reducing agent.
  • the protein in human tears can be an oxidizing agent in the reversible chemical reaction.
  • the reversible gel layer 20 When the ophthalmic lens 1 is worn, the reversible gel layer 20 can have a reversible chemical reaction under the tears protein, then the reversible gel layer 20 can be closely in contact with eyeball of the wearer, thus radius of curvature of the contact surface 101 can be changed to equal corneal radiuses of the eye of wearer.
  • the reversible gel layer 20 can includes reversible disulfide/polysulfide chemical bonds. Before being used, the reversible disulfide/polysulfide chemical bonds are disconnected. When the reversible gel layer 20 is in contact with the tears protein, the reversible disulfide/polysulfide chemical bonds can be reconnected. The reversible disulfide/polysulfide chemical bonds can be disconnected by a reducing agent, such as cysteine. Thus, the ophthalmic lens 1 can be received in a reducing agent before being used, and the reducing agent includes cysteine.
  • a reducing agent such as cysteine
  • the reversible gel layer 20 When the reversible gel layer 20 is an acid-base induced reversible gel layer, the reversible gel layer 20 can have a reversible chemical reaction under a pH value around the pH value of the human tears, which is in a range of about 6 to about 7.5. When the ophthalmic lens 1 is worn, the reversible gel layer 20 can have a reversible chemical reaction under the tears, then the reversible gel layer 20 can be closely in contact with eyeball of the wearer, thus radius of curvature of the contact surface 101 can be suitably changed.
  • FIG. 2 illustrates an exemplary embodiment of an automatically-adapting intraocular lens 3 including a reversible gel layer 30 .
  • the reversible gel layer 30 can be made of hydrogel or silicone hydrogel.
  • the reversible gel layer 30 is made of hydrogel
  • the reversible gel layer 30 is made of silicone hydrogel
  • the reversible gel layer 30 includes a contact surface 301 for being in contact with eye of wearer.
  • the reversible gel layer 30 When intraocular lens 3 is placed on the eye, the reversible gel layer 30 can have a reversible chemical reaction which changes its shape.
  • the physical movement of molecular structure in the reversible gel layer 30 being limited by the eye of wearer, the reversible gel layer 30 can be closely in contact with eyeball of the wearer, thus radius of curvature of the contact surface 301 can be suitably changed.
  • the reversible gel layer 30 can be a thermally reversible gel layer, a light induced reversible gel layer, a redox agent induced reversible gel layer, or an acid-base (pH value) induced reversible gel layer.
  • the reversible gel layer 30 can includes a block copolymer, and the block copolymer can have a reversible chemical reaction which changes its shape under a change of temperature.
  • a temperature is around the temperature of a human body, such as in a range of 30 degrees Celsius to 40 degrees Celsius, the reversible gel layer 30 is polymerized and solidifies.
  • the block copolymer When the intraocular lens 3 is worn, the block copolymer can have a reversible chemical reaction under the body temperature, then the reversible gel layer 30 can be closely in contact with eyeball of the wearer, thus, radius of curvature of the contact surface 301 changes to equal to radiuses of corneal curvature of the eye of wearer.
  • the block copolymer can be ethylene-oxide-propylene-oxide block copolymer, polyoxyethylene-polyoxypropylene block copolymer, or other thermally reversible block copolymer.
  • the reversible gel layer 30 When the reversible gel layer 30 is a light induced reversible gel layer, the reversible gel layer 30 can have a reversible chemical reaction under an irradiation by light. When the intraocular lens 3 is worn, the reversible gel layer 30 can have a reversible chemical reaction under sunlight or ultraviolet (UV) light, then the reversible gel layer 30 can be closely in contact with eyeball of the wearer, thus, radius of curvature of the contact surface 101 can be changed to equal to radiuses of corneal curvature of the eye of wearer.
  • UV ultraviolet
  • the reversible gel layer 30 can includes one or more of disulfide chemical bonds, hydrazone chemical bonds, phenyl boronic acid chemical bonds, metal coordination bonds, and cyclodextrin host-guest interaction bond.
  • the reversible gel layer 30 can further includes catalyst of light.
  • the reversible gel layer 30 When the reversible gel layer 30 is a redox agent induced reversible gel layer, the reversible gel layer 30 can have a reversible chemical reaction under an oxidizing agent or a reducing agent.
  • the protein in human tears can be an oxidizing agent in the reversible chemical reaction.
  • the reversible gel layer 30 When the intraocular lens 3 is worn, the reversible gel layer 30 can have a reversible chemical reaction under the tears protein, then the reversible gel layer 30 can be closely in contact with eyeball of the wearer, thus, radius of curvature of the contact surface 301 can be changed to equal to radiuses of corneal curvature of the eye of wearer.
  • the reversible gel layer 30 can includes reversible disulfide/polysulfide chemical bonds. Before being used, the reversible disulfide/polysulfide chemical bonds are disconnected. When the reversible gel layer 30 is in contact with the tears protein, the reversible disulfide/polysulfide chemical bonds can be reconnected. The reversible disulfide/polysulfide chemical bonds can be disconnected by a reducing agent, such as cysteine. Thus, the intraocular lens 3 can be received in a reducing agent before being used.
  • a reducing agent such as cysteine
  • the reversible gel layer 30 When the reversible gel layer 30 is an acid-base induced reversible gel layer, the reversible gel layer 30 can have a reversible chemical reaction under a pH value around a pH value of the human tears, which is in a range of about 6 to about 7.5.
  • the reversible gel layer 30 When the intraocular lens 3 is worn, the reversible gel layer 30 can have a reversible chemical reaction under the tear, then the reversible gel layer 30 can be closely in contact with eyeball of the wearer, thus, radius of curvature of the contact surface 301 can be changed to equal to radiuses of corneal curvature of the eye of wearer.

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

An intraocular/intraocular lens which automatically adapts in radius to the corneal radius of the eye of a user includes a reversible gel layer. The reversible gel layer includes a contact surface. Radius of curvature of the contact surface changes when under a chemical reaction of the reversible gel layer induced by temperature, light, or acidity, the reaction being reversible.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application claims priority to Taiwanese Patent Application No. 106121027 filed on Jun. 23, 2017, the contents of which are incorporated by reference herein.
  • FIELD
  • The subject matter herein generally relates to eye health, and automatically-adapting ophthalmic lens and intraocular lens.
  • BACKGROUND
  • Ophthalmic/intraocular lens are commonly worn by users to correct vision, or for cosmetic or therapeutic reasons. Usually, radius of curvature of an ophthalmic/intraocular lens is predetermined. However, radiuses of cornea curvature of different users are very different, and an ophthalmic/intraocular lens having a predetermined radius of curvature probably will not be matched with the corneas of different users.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Implementations of the present technology will now be described, by way of example only, with reference to the attached figures.
  • FIG. 1 is a cross-sectional view of an ophthalmic lens according to an exemplary embodiment.
  • FIG. 2 is a cross-sectional view of an intraocular lens according to an exemplary embodiment.
  • DETAILED DESCRIPTION
  • It will be appreciated that for simplicity and clarity of illustration, where appropriate, reference numerals have been repeated among the different figures to indicate corresponding or analogous elements. In addition, numerous specific details are set forth in order to provide a thorough understanding of the exemplary embodiments described herein. However, it will understood by those of ordinary skill in the art that the exemplary embodiments described herein can be practiced without these specific details. In other instances, methods, procedures, and components have not been described in detail so as not to obscure the related relevant feature being described. Also, the description is not to be considered as limiting the scope of the exemplary embodiments described herein. The drawings are not necessarily to scale and the proportions of certain sections have been exaggerated to better illustrate details and features of the present disclosure.
  • Several definitions that apply throughout this disclosure will now be presented.
  • The term “comprising,” when utilized, means “including, but not necessarily limited to”; it specifically indicates open-ended inclusion or membership in the so-described combination, group, series, and the like.
  • FIG. 1 illustrates an exemplary embodiment of an automatically-adapting ophthalmic lens 1 including a matrix 10 and a reversible gel layer 20.
  • The matrix 10 and the reversible gel layer 20 all can be made of hydrogel or silicone hydrogel.
  • In at least one embodiment, when the ophthalmic lens is a hydrogel lens, the matrix 10 and the reversible gel layer 20 are made of hydrogel, and, when the ophthalmic lens is a silicone hydrogel lens, the matrix 10 and the reversible gel layer 20 are made of silicone hydrogel.
  • The matrix 10 includes a back surface 101. The reversible gel layer 20 is formed on the back surface 101. The reversible gel layer 20 includes a contact surface 201 away from the back surface 101.
  • In this exemplary embodiment, radius of curvature of the contact surface 101 can be 8.8 millimeters, 8.6 millimeters, or 8.4 millimeters, before the ophthalmic lens 1 is worn.
  • When ophthalmic lens 1 is placed on the eye, the reversible gel layer 20 can have a reversible chemical reaction which changes its shape. The physical movement of molecular structure in the reversible gel layer 20 being limited by the eye of wearer, the reversible gel layer 20 can be closely in contact with eyeball of the wearer, thus radius of curvature of the contact surface 201 changes to match radius of corneal curvature of eye of wearer.
  • The reversible gel layer 20 can be a thermally reversible gel layer, a light induced reversible gel layer, a redox agent induced reversible gel layer, or an acid-base (pH value) induced reversible gel layer.
  • When the reversible gel layer 20 is a thermally reversible gel layer, the reversible gel layer 20 can includes thermally reversible block copolymer, and the thermally reversible block copolymer can have a reversible chemical reaction which changes its shape under a change of temperature. Such as, when a temperature is around the temperature of a human body, such as in a range of 30 degrees Celsius to 40 degrees Celsius, the reversible chemical bonds are polymerized, and the reversible gel layer 20 solidifies. When the ophthalmic lens 1 is worn, the block copolymer can have a reversible chemical reaction under the body temperature, then the reversible gel layer 20 can be closely in contact with eyeball of the wearer, thus radius of curvature of the contact surface 101 changes to equal to radiuses of corneal curvature of the eye of wearer.
  • The block copolymer can be ethylene-oxide-propylene-oxide block copolymer, polyoxyethylene-polyoxypropylene block copolymer, or other thermally reversible block copolymer.
  • When the reversible gel layer 20 is a light induced reversible gel layer, the reversible gel layer 20 can have a reversible chemical reaction under an irradiation by light. When the ophthalmic lens 1 is worn, the reversible gel layer 20 can have a reversible chemical reaction under sunlight or ultraviolet (UV) light, then the reversible gel layer 20 can be closely in contact with eyeball of the wearer, thus radius of curvature of the contact surface 101 can be changed to equal corneal radius of the eye of wearer.
  • The reversible gel layer 20 can include one or more of disulfide chemical bonds, hydrazone chemical bonds, phenyl boronic acid chemical bonds, metal coordination bonds, and cyclodextrin host-guest interaction bonds. The reversible gel layer 20 can further include catalyst of light.
  • When the reversible gel layer 20 is a redox agent induced reversible gel layer, the reversible gel layer 20 can have a reversible chemical reaction under an oxidizing agent or a reducing agent. The protein in human tears can be an oxidizing agent in the reversible chemical reaction. When the ophthalmic lens 1 is worn, the reversible gel layer 20 can have a reversible chemical reaction under the tears protein, then the reversible gel layer 20 can be closely in contact with eyeball of the wearer, thus radius of curvature of the contact surface 101 can be changed to equal corneal radiuses of the eye of wearer.
  • The reversible gel layer 20 can includes reversible disulfide/polysulfide chemical bonds. Before being used, the reversible disulfide/polysulfide chemical bonds are disconnected. When the reversible gel layer 20 is in contact with the tears protein, the reversible disulfide/polysulfide chemical bonds can be reconnected. The reversible disulfide/polysulfide chemical bonds can be disconnected by a reducing agent, such as cysteine. Thus, the ophthalmic lens 1 can be received in a reducing agent before being used, and the reducing agent includes cysteine.
  • When the reversible gel layer 20 is an acid-base induced reversible gel layer, the reversible gel layer 20 can have a reversible chemical reaction under a pH value around the pH value of the human tears, which is in a range of about 6 to about 7.5. When the ophthalmic lens 1 is worn, the reversible gel layer 20 can have a reversible chemical reaction under the tears, then the reversible gel layer 20 can be closely in contact with eyeball of the wearer, thus radius of curvature of the contact surface 101 can be suitably changed.
  • FIG. 2 illustrates an exemplary embodiment of an automatically-adapting intraocular lens 3 including a reversible gel layer 30.
  • The reversible gel layer 30 can be made of hydrogel or silicone hydrogel.
  • In at least one embodiment, when the intraocular lens 3 is a hydrogel lens, the reversible gel layer 30 is made of hydrogel, and when the intraocular lens 3 is a silicone hydrogel lens, the reversible gel layer 30 is made of silicone hydrogel.
  • The reversible gel layer 30 includes a contact surface 301 for being in contact with eye of wearer.
  • When intraocular lens 3 is placed on the eye, the reversible gel layer 30 can have a reversible chemical reaction which changes its shape. The physical movement of molecular structure in the reversible gel layer 30 being limited by the eye of wearer, the reversible gel layer 30 can be closely in contact with eyeball of the wearer, thus radius of curvature of the contact surface 301 can be suitably changed.
  • The reversible gel layer 30 can be a thermally reversible gel layer, a light induced reversible gel layer, a redox agent induced reversible gel layer, or an acid-base (pH value) induced reversible gel layer.
  • When the reversible gel layer 30 is a thermally reversible gel layer, the reversible gel layer 30 can includes a block copolymer, and the block copolymer can have a reversible chemical reaction which changes its shape under a change of temperature. Such as, when a temperature is around the temperature of a human body, such as in a range of 30 degrees Celsius to 40 degrees Celsius, the reversible gel layer 30 is polymerized and solidifies. When the intraocular lens 3 is worn, the block copolymer can have a reversible chemical reaction under the body temperature, then the reversible gel layer 30 can be closely in contact with eyeball of the wearer, thus, radius of curvature of the contact surface 301 changes to equal to radiuses of corneal curvature of the eye of wearer.
  • The block copolymer can be ethylene-oxide-propylene-oxide block copolymer, polyoxyethylene-polyoxypropylene block copolymer, or other thermally reversible block copolymer.
  • When the reversible gel layer 30 is a light induced reversible gel layer, the reversible gel layer 30 can have a reversible chemical reaction under an irradiation by light. When the intraocular lens 3 is worn, the reversible gel layer 30 can have a reversible chemical reaction under sunlight or ultraviolet (UV) light, then the reversible gel layer 30 can be closely in contact with eyeball of the wearer, thus, radius of curvature of the contact surface 101 can be changed to equal to radiuses of corneal curvature of the eye of wearer.
  • The reversible gel layer 30 can includes one or more of disulfide chemical bonds, hydrazone chemical bonds, phenyl boronic acid chemical bonds, metal coordination bonds, and cyclodextrin host-guest interaction bond. The reversible gel layer 30 can further includes catalyst of light.
  • When the reversible gel layer 30 is a redox agent induced reversible gel layer, the reversible gel layer 30 can have a reversible chemical reaction under an oxidizing agent or a reducing agent. The protein in human tears can be an oxidizing agent in the reversible chemical reaction. When the intraocular lens 3 is worn, the reversible gel layer 30 can have a reversible chemical reaction under the tears protein, then the reversible gel layer 30 can be closely in contact with eyeball of the wearer, thus, radius of curvature of the contact surface 301 can be changed to equal to radiuses of corneal curvature of the eye of wearer.
  • The reversible gel layer 30 can includes reversible disulfide/polysulfide chemical bonds. Before being used, the reversible disulfide/polysulfide chemical bonds are disconnected. When the reversible gel layer 30 is in contact with the tears protein, the reversible disulfide/polysulfide chemical bonds can be reconnected. The reversible disulfide/polysulfide chemical bonds can be disconnected by a reducing agent, such as cysteine. Thus, the intraocular lens 3 can be received in a reducing agent before being used.
  • When the reversible gel layer 30 is an acid-base induced reversible gel layer, the reversible gel layer 30 can have a reversible chemical reaction under a pH value around a pH value of the human tears, which is in a range of about 6 to about 7.5. When the intraocular lens 3 is worn, the reversible gel layer 30 can have a reversible chemical reaction under the tear, then the reversible gel layer 30 can be closely in contact with eyeball of the wearer, thus, radius of curvature of the contact surface 301 can be changed to equal to radiuses of corneal curvature of the eye of wearer.
  • The exemplary embodiments shown and described above are only examples. Many details are often found in the art such as the other features of an intraocular lens 3. Therefore, many such details are neither shown nor described. Even though numerous characteristics and advantages of the present technology have been set forth in the foregoing description, together with details of the structure and function of the present disclosure, the disclosure is illustrative only, and changes may be made in the detail, especially in matters of shape, size, and arrangement of the sections within the principles of the present disclosure, up to and including the full extent established by the broad general meaning of the terms used in the claims. It will therefore be appreciated that the exemplary embodiments described above may be modified within the scope of the claims.

Claims (20)

What is claimed is:
1. An automatically-adapting ophthalmic lens, comprising:
a reversible gel layer, the reversible gel layer comprising a contact surface;
wherein radius of curvature of the contact surface changes when under a reversible chemical reaction of the reversible gel layer.
2. The automatically-adapting ophthalmic lens of claim 1, wherein the reversible gel layer is a thermally reversible gel layer, the reversible gel layer has a reversible chemical reaction when under a temperature around the temperature of a human body.
3. The automatically-adapting ophthalmic lens of claim 2, wherein the reversible gel layer comprises thermally reversible block copolymer.
4. The automatically-adapting ophthalmic lens of claim 1, wherein the reversible gel layer is a light induced reversible gel layer, the reversible gel layer has a reversible chemical reaction when under the sunlight or ultraviolet light.
5. The automatically-adapting ophthalmic lens of claim 4, wherein the reversible gel layer comprises disulfide chemical bonds, hydrazone chemical bonds, phenyl boronic acid chemical bonds, metal coordination bonds, cyclodextrin host-guest interaction bonds, or any combination thereof.
6. The automatically-adapting ophthalmic lens of claim 4, wherein the reversible gel layer further comprises catalyst of light.
7. The automatically-adapting ophthalmic lens of claim 1, wherein the reversible gel layer is a redox agent induced reversible gel layer, the reversible gel layer has a reversible chemical reaction when under an oxidizing agent or a reducing agent.
8. The automatically-adapting ophthalmic lens of claim 7, wherein the reversible gel layer comprises reversible disulfide/polysulfide chemical bonds, before being used, the reversible disulfide/polysulfide chemical bonds are disconnected, when the reversible gel layer is in contact with the protein in human tears, the reversible disulfide/polysulfide chemical bonds is reconnected.
9. The automatically-adapting ophthalmic lens of claim 7, wherein the ophthalmic lens is received in reducing agent, the reducing agent comprises cysteine.
10. The automatically-adapting ophthalmic lens of claim 1, wherein the reversible gel layer is an acid-base induced reversible gel layer, the reversible gel layer has a reversible chemical reaction when under a pH value around the pH value of human tears.
11. An automatically-adapting intraocular lens, comprising:
a reversible gel layer, the reversible gel layer comprising a contact surface;
wherein radius of curvature of the contact surface changes when under a reversible chemical reaction of the reversible gel layer.
12. The automatically-adapting intraocular lens of claim 11, wherein the reversible gel layer is a thermally reversible gel layer, the reversible gel layer has a reversible chemical reaction when under a temperature around the temperature of a human body.
13. The automatically-adapting intraocular lens of claim 12, wherein the reversible gel layer comprises thermally reversible block copolymer.
14. The automatically-adapting intraocular lens of claim 11, wherein the reversible gel layer is a light induced reversible gel layer, the reversible gel layer has a reversible chemical reaction when under the sunlight or ultraviolet light.
15. The automatically-adapting intraocular lens of claim 14, wherein the reversible gel layer comprises disulfide chemical bonds, hydrazone chemical bonds, phenyl boronic acid chemical bonds, metal coordination bonds, cyclodextrin host-guest interaction bonds, or any combination thereof.
16. The automatically-adapting intraocular lens of claim 14, wherein the reversible gel layer further comprises catalyst of light.
17. The automatically-adapting intraocular lens of claim 11, wherein the reversible gel layer is a redox agent induced reversible gel layer, the reversible gel layer has a reversible chemical reaction when under an oxidizing agent or a reducing agent.
18. The automatically-adapting intraocular lens of claim 17, wherein the reversible gel layer comprises reversible disulfide/polysulfide chemical bonds, before being used, the reversible disulfide/polysulfide chemical bonds are disconnected, when the reversible gel layer is in contact with the protein of human tears, the reversible disulfide/polysulfide chemical bonds is reconnected.
19. The automatically-adapting intraocular lens of claim 17, wherein the intraocular lens is received in reducing agent, the reducing agent comprises cysteine.
20. The automatically-adapting intraocular lens of claim 11, wherein the reversible gel layer is an acid-base induced reversible gel layer, the reversible gel layer has a reversible chemical reaction when under a pH value around the pH value of human tears.
US15/638,835 2017-06-23 2017-06-30 Automatically-adapting ophthalmic lens and intraocular lens Expired - Fee Related US10162193B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TW106121027A 2017-06-23
TW106121027A TW201904529A (en) 2017-06-23 2017-06-23 Ophthalmic lens and intraocular lens
TW106121027 2017-06-23

Publications (2)

Publication Number Publication Date
US10162193B1 US10162193B1 (en) 2018-12-25
US20180373061A1 true US20180373061A1 (en) 2018-12-27

Family

ID=64692187

Family Applications (1)

Application Number Title Priority Date Filing Date
US15/638,835 Expired - Fee Related US10162193B1 (en) 2017-06-23 2017-06-30 Automatically-adapting ophthalmic lens and intraocular lens

Country Status (2)

Country Link
US (1) US10162193B1 (en)
TW (1) TW201904529A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI640307B (en) * 2017-12-27 2018-11-11 優你康光學股份有限公司 Dual defocus lens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9046699B2 (en) * 2012-03-13 2015-06-02 Johnson & Johnson Vision Care, Inc. Dynamic fluid zones in contact lenses

Also Published As

Publication number Publication date
TW201904529A (en) 2019-02-01
US10162193B1 (en) 2018-12-25

Similar Documents

Publication Publication Date Title
US8960901B2 (en) Myopia control ophthalmic lenses
JP7516262B2 (en) Dynamically tunable apodized multifocal ophthalmic device and method - Patents.com
WO2007142981A3 (en) Methods and apparatus for improving vision
HK1212194A1 (en) Lenses, devices, methods and systems for refractive error
MY170667A (en) Lenses, devices, methods and systems for refractive error
MY147505A (en) Ophthalmic lens element for myopia correction
WO2007021579A3 (en) Contact lenses and methods for reducing conjunctival pressure in contact lens wearers
AR041743A1 (en) MULTIFOCAL CONTACT LENSES REGULATED BY THE PUPIL
WO2004015479A3 (en) Orthokeratology and bi-focal contact lens
JP2013178517A (en) Multi-axis lens design for astigmatism
WO2005062818A3 (en) Treatment of ophthalmic conditions
US12235522B2 (en) Lens with displaced shaping zone
JP2016507083A5 (en)
TW200914912A (en) Lens designs for treating asthenopia caused by visual defects
US10162193B1 (en) Automatically-adapting ophthalmic lens and intraocular lens
Yuan et al. Development of corneal contact lens materials and current clinical application of contact lenses: a review
US10080494B2 (en) Eye lens and cornea monitoring system using the same
JP2023544898A (en) Contact lens position and rotation control using eyelid margin pressure
TWI553372B (en) Intelligent patch for contact lens
US20200341296A1 (en) Aspheric lens capable of using monocular retinal rivalry to control axial length grown rate
Adrus et al. Contact Lenses
Conlin et al. The Refractive State of the Human Eye
US20230086646A1 (en) Therapeutic Eyewear Sleeve
KR20210053427A (en) Blue Light Contact Lenses
CN105334639A (en) Color Image Patches for Contact Lenses

Legal Events

Date Code Title Description
AS Assignment

Owner name: HON HAI PRECISION INDUSTRY CO., LTD., TAIWAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CHIEN, HSIU-WEN;REEL/FRAME:042874/0190

Effective date: 20170622

AS Assignment

Owner name: SCIENBIZIP CONSULTING(SHENZHEN)CO.,LTD., CHINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HON HAI PRECISION INDUSTRY CO., LTD.;REEL/FRAME:046795/0978

Effective date: 20180827

AS Assignment

Owner name: MIICS & PARTNERS (SHENZHEN) CO., LTD., CHINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SCIENBIZIP CONSULTING(SHENZHEN)CO.,LTD.;REEL/FRAME:046917/0305

Effective date: 20180919

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20221225